APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical Decommissioning Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pharmaceutical Decommissioning Service Market Analysis and Forecast 2026-2032

16 April 2026187 pages

Choose your research edition.

Industry ResearchPharmaceutical Decommissioning Service Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical Decommissioning Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Pharmaceutical Decommissioning Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical Decommissioning Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical Decommissioning Service Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global Pharmaceutical Decommissioning Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Pharmaceutical Decommissioning Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pharmaceutical Decommissioning Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pharmaceutical Decommissioning Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pharmaceutical Decommissioning Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Pharmaceutical Decommissioning Service include KDC Veolia, RCS Pharma, Technical Safety Services, ISPE, Brilliant Equipment Services, Qualitech Environmental Services, Hughes & Salvidge, Divestiture and Pharmagraph, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Pharmaceutical Decommissioning Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pharmaceutical Decommissioning Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Pharmaceutical Decommissioning Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharmaceutical Decommissioning Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pharmaceutical Decommissioning Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Pharmaceutical Decommissioning Service revenue, projected growth trends, production technology, application and end-user industry.

Pharmaceutical Decommissioning Service Segment by Company

KDC Veolia

RCS Pharma

Technical Safety Services

ISPE

Brilliant Equipment Services

Qualitech Environmental Services

Hughes & Salvidge

Divestiture

Pharmagraph

RVA Group

DSM Demolition

KERAMIDA Inc

Downwell Enabling Solutions

Pharmaceutical Decommissioning Service Segment by Type

Equipment Decommissioning Service

Facility Decommissioning Service

Laboratory Decommissioning Service

Others

Pharmaceutical Decommissioning Service Segment by Application

Pharmaceutical Manufacturers

Pharmaceutical CDMO

Pharmaceutical Decommissioning Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical Decommissioning Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical Decommissioning Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical Decommissioning Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Pharmaceutical Decommissioning Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Pharmaceutical Decommissioning Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pharmaceutical Decommissioning Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pharmaceutical Decommissioning Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Equipment Decommissioning Service Major Player Table 3. Facility Decommissioning Service Major Player Table 4. Laboratory Decommissioning Service Major Player Table 5. Others Major Player Table 6. Global Pharmaceutical Decommissioning Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical Manufacturers Major Player Table 8. Pharmaceutical CDMO Major Player Table 9. Pharmaceutical Decommissioning Service Industry Trends Table 10. Pharmaceutical Decommissioning Service Industry Drivers Table 11. Pharmaceutical Decommissioning Service Industry Opportunities and Challenges Table 12. Pharmaceutical Decommissioning Service Industry Restraints Table 13. Global Pharmaceutical Decommissioning Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Pharmaceutical Decommissioning Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Pharmaceutical Decommissioning Service Market Share by Region (2021-2026) Table 16. Global Pharmaceutical Decommissioning Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Pharmaceutical Decommissioning Service Market Share by Region (2027-2032) Table 18. Global Pharmaceutical Decommissioning Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Pharmaceutical Decommissioning Service Revenue Market Share by Players (2021-2026) Table 20. Global Pharmaceutical Decommissioning Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pharmaceutical Decommissioning Service Key Players Headquarters & Area Served Table 22. Global Pharmaceutical Decommissioning Service Players, Product Type & Application Table 23. Global Pharmaceutical Decommissioning Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Pharmaceutical Decommissioning Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Pharmaceutical Decommissioning Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pharmaceutical Decommissioning Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Pharmaceutical Decommissioning Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Pharmaceutical Decommissioning Service Revenue Market Share by Type (2021-2026) Table 30. Global Pharmaceutical Decommissioning Service Revenue Market Share by Type (2027-2032) Table 31. Global Pharmaceutical Decommissioning Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pharmaceutical Decommissioning Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Pharmaceutical Decommissioning Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Pharmaceutical Decommissioning Service Revenue Market Share by Application (2021-2026) Table 35. Global Pharmaceutical Decommissioning Service Revenue Market Share by Application (2027-2032) Table 36. KDC Veolia Company Information Table 37. KDC Veolia Business Overview Table 38. KDC Veolia Pharmaceutical Decommissioning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. KDC Veolia Pharmaceutical Decommissioning Service Product Portfolio Table 40. KDC Veolia Recent Development Table 41. RCS Pharma Company Information Table 42. RCS Pharma Business Overview Table 43. RCS Pharma Pharmaceutical Decommissioning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. RCS Pharma Pharmaceutical Decommissioning Service Product Portfolio Table 45. RCS Pharma Recent Development Table 46. Technical Safety Services Company Information Table 47. Technical Safety Services Business Overview Table 48. Technical Safety Services Pharmaceutical Decommissioning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Technical Safety Services Pharmaceutical Decommissioning Service Product Portfolio Table 50. Technical Safety Services Recent Development Table 51. ISPE Company Information Table 52. ISPE Business Overview Table 53. ISPE Pharmaceutical Decommissioning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. ISPE Pharmaceutical Decommissioning Service Product Portfolio Table 55. ISPE Recent Development Table 56. Brilliant Equipment Services Company Information Table 57. Brilliant Equipment Services Business Overview Table 58. Brilliant Equipment Services Pharmaceutical Decommissioning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Brilliant Equipment Services Pharmaceutical Decommissioning Service Product Portfolio Table 60. Brilliant Equipment Services Recent Development Table 61. Qualitech Environmental Services Company Information Table 62. Qualitech Environmental Services Business Overview Table 63. Qualitech Environmental Services Pharmaceutical Decommissioning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Qualitech Environmental Services Pharmaceutical Decommissioning Service Product Portfolio Table 65. Qualitech Environmental Services Recent Development Table 66. Hughes & Salvidge Company Information Table 67. Hughes & Salvidge Business Overview Table 68. Hughes & Salvidge Pharmaceutical Decommissioning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Hughes & Salvidge Pharmaceutical Decommissioning Service Product Portfolio Table 70. Hughes & Salvidge Recent Development Table 71. Divestiture Company Information Table 72. Divestiture Business Overview Table 73. Divestiture Pharmaceutical Decommissioning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Divestiture Pharmaceutical Decommissioning Service Product Portfolio Table 75. Divestiture Recent Development Table 76. Pharmagraph Company Information Table 77. Pharmagraph Business Overview Table 78. Pharmagraph Pharmaceutical Decommissioning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Pharmagraph Pharmaceutical Decommissioning Service Product Portfolio Table 80. Pharmagraph Recent Development Table 81. RVA Group Company Information Table 82. RVA Group Business Overview Table 83. RVA Group Pharmaceutical Decommissioning Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. RVA Group Pharmaceutical Decommissioning Service Product Portfolio Table 85. RVA Group Recent Development Table 86. DSM Demolition Company Information Table 87. DSM Demolition Business Overview Table 88. DSM Demolition Pharmaceutical Decommissioning Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. DSM Demolition Pharmaceutical Decommissioning Service Product Portfolio Table 90. DSM Demolition Recent Development Table 91. KERAMIDA Inc Company Information Table 92. KERAMIDA Inc Business Overview Table 93. KERAMIDA Inc Pharmaceutical Decommissioning Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. KERAMIDA Inc Pharmaceutical Decommissioning Service Product Portfolio Table 95. KERAMIDA Inc Recent Development Table 96. Downwell Enabling Solutions Company Information Table 97. Downwell Enabling Solutions Business Overview Table 98. Downwell Enabling Solutions Pharmaceutical Decommissioning Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Downwell Enabling Solutions Pharmaceutical Decommissioning Service Product Portfolio Table 100. Downwell Enabling Solutions Recent Development Table 101. North America Pharmaceutical Decommissioning Service Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Pharmaceutical Decommissioning Service Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Pharmaceutical Decommissioning Service Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Pharmaceutical Decommissioning Service Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Pharmaceutical Decommissioning Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Pharmaceutical Decommissioning Service Revenue by Country (2021-2026) & (US$ Million) Table 107. North America Pharmaceutical Decommissioning Service Revenue by Country (US$ Million) & (2027-2032) Table 108. Europe Pharmaceutical Decommissioning Service Revenue by Type (2021-2026) & (US$ Million) Table 109. Europe Pharmaceutical Decommissioning Service Revenue by Type (2027-2032) & (US$ Million) Table 110. Europe Pharmaceutical Decommissioning Service Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Pharmaceutical Decommissioning Service Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Pharmaceutical Decommissioning Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. Europe Pharmaceutical Decommissioning Service Revenue by Country (2021-2026) & (US$ Million) Table 114. Europe Pharmaceutical Decommissioning Service Revenue by Country (US$ Million) & (2027-2032) Table 115. China Pharmaceutical Decommissioning Service Revenue by Type (2021-2026) & (US$ Million) Table 116. China Pharmaceutical Decommissioning Service Revenue by Type (2027-2032) & (US$ Million) Table 117. China Pharmaceutical Decommissioning Service Revenue by Application (2021-2026) & (US$ Million) Table 118. China Pharmaceutical Decommissioning Service Revenue by Application (2027-2032) & (US$ Million) Table 119. Asia Pharmaceutical Decommissioning Service Revenue by Type (2021-2026) & (US$ Million) Table 120. Asia Pharmaceutical Decommissioning Service Revenue by Type (2027-2032) & (US$ Million) Table 121. Asia Pharmaceutical Decommissioning Service Revenue by Application (2021-2026) & (US$ Million) Table 122. Asia Pharmaceutical Decommissioning Service Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Pharmaceutical Decommissioning Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Asia Pharmaceutical Decommissioning Service Revenue by Region (US$ Million) & (2021-2026) Table 125. Asia Pharmaceutical Decommissioning Service Revenue by Region (US$ Million) & (2027-2032) Table 126. SAMEA Pharmaceutical Decommissioning Service Revenue by Type (2021-2026) & (US$ Million) Table 127. SAMEA Pharmaceutical Decommissioning Service Revenue by Type (2027-2032) & (US$ Million) Table 128. SAMEA Pharmaceutical Decommissioning Service Revenue by Application (2021-2026) & (US$ Million) Table 129. SAMEA Pharmaceutical Decommissioning Service Revenue by Application (2027-2032) & (US$ Million) Table 130. SAMEA Pharmaceutical Decommissioning Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. SAMEA Pharmaceutical Decommissioning Service Revenue by Country (2021-2026) & (US$ Million) Table 132. SAMEA Pharmaceutical Decommissioning Service Revenue by Country (US$ Million) & (2027-2032) Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Pharmaceutical Decommissioning Service Image Figure 2. Global Pharmaceutical Decommissioning Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical Decommissioning Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Equipment Decommissioning Service Image Figure 5. Facility Decommissioning Service Image Figure 6. Laboratory Decommissioning Service Image Figure 7. Others Image Figure 8. Global Pharmaceutical Decommissioning Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Pharmaceutical Decommissioning Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical Manufacturers Image Figure 11. Pharmaceutical CDMO Image Figure 12. Global Pharmaceutical Decommissioning Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Pharmaceutical Decommissioning Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Pharmaceutical Decommissioning Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Pharmaceutical Decommissioning Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Pharmaceutical Decommissioning Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Pharmaceutical Decommissioning Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Pharmaceutical Decommissioning Service Revenue Market Share by Type (2021-2032) Figure 20. Global Pharmaceutical Decommissioning Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Pharmaceutical Decommissioning Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Pharmaceutical Decommissioning Service Revenue Market Share by Application (2021-2032) Figure 23. North America Pharmaceutical Decommissioning Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Pharmaceutical Decommissioning Service Revenue Share by Type (2021-2032) Figure 25. North America Pharmaceutical Decommissioning Service Revenue Share by Application (2021-2032) Figure 26. North America Pharmaceutical Decommissioning Service Revenue Share by Country (2021-2032) Figure 27. United States Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Pharmaceutical Decommissioning Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Pharmaceutical Decommissioning Service Revenue Share by Type (2021-2032) Figure 32. Europe Pharmaceutical Decommissioning Service Revenue Share by Application (2021-2032) Figure 33. Europe Pharmaceutical Decommissioning Service Revenue Share by Country (2021-2032) Figure 34. Germany Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Pharmaceutical Decommissioning Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Pharmaceutical Decommissioning Service Revenue Share by Type (2021-2032) Figure 44. China Pharmaceutical Decommissioning Service Revenue Share by Application (2021-2032) Figure 45. Asia Pharmaceutical Decommissioning Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Pharmaceutical Decommissioning Service Revenue Share by Type (2021-2032) Figure 47. Asia Pharmaceutical Decommissioning Service Revenue Share by Application (2021-2032) Figure 48. Asia Pharmaceutical Decommissioning Service Revenue Share by Region (2021-2032) Figure 49. Japan Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Pharmaceutical Decommissioning Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Pharmaceutical Decommissioning Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Pharmaceutical Decommissioning Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Pharmaceutical Decommissioning Service Revenue Share by Country (2021-2032) Figure 59. Brazil Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Pharmaceutical Decommissioning Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Equipment Decommissioning Service
  • Facility Decommissioning Service
  • Laboratory Decommissioning Service
  • Others
Applications
  • Pharmaceutical Manufacturers
  • Pharmaceutical CDMO
Companies covered
  • KDC Veolia
  • RCS Pharma
  • Technical Safety Services
  • ISPE
  • Brilliant Equipment Services
  • Qualitech Environmental Services
  • Hughes & Salvidge
  • Divestiture
  • Pharmagraph
  • RVA Group
  • DSM Demolition
  • KERAMIDA Inc
  • Downwell Enabling Solutions

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pharmaceutical Decommissioning Service Market by Type
  3. 1.2.1 Global Pharmaceutical Decommissioning Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Equipment Decommissioning Service
  5. 1.2.3 Facility Decommissioning Service
  6. 1.2.4 Laboratory Decommissioning Service
  7. 1.2.5 Others
  8. 1.3 Pharmaceutical Decommissioning Service Market by Application
  9. 1.3.1 Global Pharmaceutical Decommissioning Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Manufacturers
  11. 1.3.3 Pharmaceutical CDMO
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pharmaceutical Decommissioning Service Market Dynamics
  1. 2.1 Pharmaceutical Decommissioning Service Industry Trends
  2. 2.2 Pharmaceutical Decommissioning Service Industry Drivers
  3. 2.3 Pharmaceutical Decommissioning Service Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical Decommissioning Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Pharmaceutical Decommissioning Service Market Perspective (2021-2032)
  2. 3.2 Global Pharmaceutical Decommissioning Service Growth Trends by Region
  3. 3.2.1 Global Pharmaceutical Decommissioning Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pharmaceutical Decommissioning Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Pharmaceutical Decommissioning Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Pharmaceutical Decommissioning Service Revenue by Players
  2. 4.1.1 Global Pharmaceutical Decommissioning Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Pharmaceutical Decommissioning Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Pharmaceutical Decommissioning Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pharmaceutical Decommissioning Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Pharmaceutical Decommissioning Service Key Players Headquarters & Area Served
  7. 4.4 Global Pharmaceutical Decommissioning Service Players, Product Type & Application
  8. 4.5 Global Pharmaceutical Decommissioning Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Pharmaceutical Decommissioning Service Market CR5 and HHI
  11. 4.6.3 2025 Pharmaceutical Decommissioning Service Tier 1, Tier 2, and Tier 3
5 Pharmaceutical Decommissioning Service Market Size by Type
  1. 5.1 Global Pharmaceutical Decommissioning Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Pharmaceutical Decommissioning Service Revenue by Type (2021-2032)
  3. 5.3 Global Pharmaceutical Decommissioning Service Revenue Market Share by Type (2021-2032)
6 Pharmaceutical Decommissioning Service Market Size by Application
  1. 6.1 Global Pharmaceutical Decommissioning Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Pharmaceutical Decommissioning Service Revenue by Application (2021-2032)
  3. 6.3 Global Pharmaceutical Decommissioning Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 KDC Veolia
  2. 7.1.1 KDC Veolia Company Information
  3. 7.1.2 KDC Veolia Business Overview
  4. 7.1.3 KDC Veolia Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 KDC Veolia Pharmaceutical Decommissioning Service Product Portfolio
  6. 7.1.5 KDC Veolia Recent Developments
  7. 7.2 RCS Pharma
  8. 7.2.1 RCS Pharma Company Information
  9. 7.2.2 RCS Pharma Business Overview
  10. 7.2.3 RCS Pharma Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 RCS Pharma Pharmaceutical Decommissioning Service Product Portfolio
  12. 7.2.5 RCS Pharma Recent Developments
  13. 7.3 Technical Safety Services
  14. 7.3.1 Technical Safety Services Company Information
  15. 7.3.2 Technical Safety Services Business Overview
  16. 7.3.3 Technical Safety Services Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Technical Safety Services Pharmaceutical Decommissioning Service Product Portfolio
  18. 7.3.5 Technical Safety Services Recent Developments
  19. 7.4 ISPE
  20. 7.4.1 ISPE Company Information
  21. 7.4.2 ISPE Business Overview
  22. 7.4.3 ISPE Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ISPE Pharmaceutical Decommissioning Service Product Portfolio
  24. 7.4.5 ISPE Recent Developments
  25. 7.5 Brilliant Equipment Services
  26. 7.5.1 Brilliant Equipment Services Company Information
  27. 7.5.2 Brilliant Equipment Services Business Overview
  28. 7.5.3 Brilliant Equipment Services Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Brilliant Equipment Services Pharmaceutical Decommissioning Service Product Portfolio
  30. 7.5.5 Brilliant Equipment Services Recent Developments
  31. 7.6 Qualitech Environmental Services
  32. 7.6.1 Qualitech Environmental Services Company Information
  33. 7.6.2 Qualitech Environmental Services Business Overview
  34. 7.6.3 Qualitech Environmental Services Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Qualitech Environmental Services Pharmaceutical Decommissioning Service Product Portfolio
  36. 7.6.5 Qualitech Environmental Services Recent Developments
  37. 7.7 Hughes & Salvidge
  38. 7.7.1 Hughes & Salvidge Company Information
  39. 7.7.2 Hughes & Salvidge Business Overview
  40. 7.7.3 Hughes & Salvidge Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Hughes & Salvidge Pharmaceutical Decommissioning Service Product Portfolio
  42. 7.7.5 Hughes & Salvidge Recent Developments
  43. 7.8 Divestiture
  44. 7.8.1 Divestiture Company Information
  45. 7.8.2 Divestiture Business Overview
  46. 7.8.3 Divestiture Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Divestiture Pharmaceutical Decommissioning Service Product Portfolio
  48. 7.8.5 Divestiture Recent Developments
  49. 7.9 Pharmagraph
  50. 7.9.1 Pharmagraph Company Information
  51. 7.9.2 Pharmagraph Business Overview
  52. 7.9.3 Pharmagraph Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Pharmagraph Pharmaceutical Decommissioning Service Product Portfolio
  54. 7.9.5 Pharmagraph Recent Developments
  55. 7.10 RVA Group
  56. 7.10.1 RVA Group Company Information
  57. 7.10.2 RVA Group Business Overview
  58. 7.10.3 RVA Group Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 RVA Group Pharmaceutical Decommissioning Service Product Portfolio
  60. 7.10.5 RVA Group Recent Developments
  61. 7.11 DSM Demolition
  62. 7.11.1 DSM Demolition Company Information
  63. 7.11.2 DSM Demolition Business Overview
  64. 7.11.3 DSM Demolition Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 DSM Demolition Pharmaceutical Decommissioning Service Product Portfolio
  66. 7.11.5 DSM Demolition Recent Developments
  67. 7.12 KERAMIDA Inc
  68. 7.12.1 KERAMIDA Inc Company Information
  69. 7.12.2 KERAMIDA Inc Business Overview
  70. 7.12.3 KERAMIDA Inc Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 KERAMIDA Inc Pharmaceutical Decommissioning Service Product Portfolio
  72. 7.12.5 KERAMIDA Inc Recent Developments
  73. 7.13 Downwell Enabling Solutions
  74. 7.13.1 Downwell Enabling Solutions Company Information
  75. 7.13.2 Downwell Enabling Solutions Business Overview
  76. 7.13.3 Downwell Enabling Solutions Pharmaceutical Decommissioning Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Downwell Enabling Solutions Pharmaceutical Decommissioning Service Product Portfolio
  78. 7.13.5 Downwell Enabling Solutions Recent Developments
8 North America
  1. 8.1 North America Pharmaceutical Decommissioning Service Revenue (2021-2032)
  2. 8.2 North America Pharmaceutical Decommissioning Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Pharmaceutical Decommissioning Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Pharmaceutical Decommissioning Service Revenue by Type (2027-2032)
  5. 8.3 North America Pharmaceutical Decommissioning Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Pharmaceutical Decommissioning Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Pharmaceutical Decommissioning Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Pharmaceutical Decommissioning Service Revenue by Application (2027-2032)
  9. 8.5 North America Pharmaceutical Decommissioning Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Pharmaceutical Decommissioning Service Revenue by Country
  11. 8.6.1 North America Pharmaceutical Decommissioning Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Pharmaceutical Decommissioning Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Pharmaceutical Decommissioning Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Pharmaceutical Decommissioning Service Revenue (2021-2032)
  2. 9.2 Europe Pharmaceutical Decommissioning Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Pharmaceutical Decommissioning Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Pharmaceutical Decommissioning Service Revenue by Type (2027-2032)
  5. 9.3 Europe Pharmaceutical Decommissioning Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Pharmaceutical Decommissioning Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Pharmaceutical Decommissioning Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Pharmaceutical Decommissioning Service Revenue by Application (2027-2032)
  9. 9.5 Europe Pharmaceutical Decommissioning Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Pharmaceutical Decommissioning Service Revenue by Country
  11. 9.6.1 Europe Pharmaceutical Decommissioning Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Pharmaceutical Decommissioning Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Pharmaceutical Decommissioning Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Pharmaceutical Decommissioning Service Revenue (2021-2032)
  2. 10.2 China Pharmaceutical Decommissioning Service Revenue by Type (2021-2032)
  3. 10.2.1 China Pharmaceutical Decommissioning Service Revenue by Type (2021-2026)
  4. 10.2.2 China Pharmaceutical Decommissioning Service Revenue by Type (2027-2032)
  5. 10.3 China Pharmaceutical Decommissioning Service Revenue Share by Type (2021-2032)
  6. 10.4 China Pharmaceutical Decommissioning Service Revenue by Application (2021-2032)
  7. 10.4.1 China Pharmaceutical Decommissioning Service Revenue by Application (2021-2026)
  8. 10.4.2 China Pharmaceutical Decommissioning Service Revenue by Application (2027-2032)
  9. 10.5 China Pharmaceutical Decommissioning Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pharmaceutical Decommissioning Service Revenue (2021-2032)
  2. 11.2 Asia Pharmaceutical Decommissioning Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Pharmaceutical Decommissioning Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Pharmaceutical Decommissioning Service Revenue by Type (2027-2032)
  5. 11.3 Asia Pharmaceutical Decommissioning Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Pharmaceutical Decommissioning Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Pharmaceutical Decommissioning Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Pharmaceutical Decommissioning Service Revenue by Application (2027-2032)
  9. 11.5 Asia Pharmaceutical Decommissioning Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Pharmaceutical Decommissioning Service Revenue by Country
  11. 11.6.1 Asia Pharmaceutical Decommissioning Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Pharmaceutical Decommissioning Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Pharmaceutical Decommissioning Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pharmaceutical Decommissioning Service Revenue (2021-2032)
  2. 12.2 SAMEA Pharmaceutical Decommissioning Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Pharmaceutical Decommissioning Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Pharmaceutical Decommissioning Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Pharmaceutical Decommissioning Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Pharmaceutical Decommissioning Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Pharmaceutical Decommissioning Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Pharmaceutical Decommissioning Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Pharmaceutical Decommissioning Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Pharmaceutical Decommissioning Service Revenue by Country
  11. 12.6.1 SAMEA Pharmaceutical Decommissioning Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Pharmaceutical Decommissioning Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Pharmaceutical Decommissioning Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst